Central Virginia

A WMRA podcast alludes to UVA's role in the biotechnology industry in Central Virginia.

Insulin delivery technology developed at UVA and commercialized by TypeZero Technologies, Inc. received initial support from UVA's Licensing and Ventures Group (LVG).

The UVA Licensing & Ventures Group (LVG) has invested in three Charlottesville-based ventures that grew out of University research. TypeZero Technologies Inc., TearSolutions Inc., and Mission Secure Inc.

Mission Secure Inc. recently announced the closing of an $8 million Series A financing round led by Energy Innovation Capital and Chevron Technology Ventures.

Plans are underway to create ease of connection between UVA's Research Park, CHO, and the Hollymead Town Center to benefit Virginia visitors and businesses.

Industry clusters are groups of firms that gain a competitive advantage by co-locating in a geographic region and sharing assets, networks, knowledge, workforce training, etc. The Office of Economic Development partners with allies to help support…

UVA was named a National Science Foundation I-Corps Site—one of 89 such sites at universities in the nation—to help entrepreneurs consider customer feedback in developing ideas that are relevant to society and exhibit applications for commerciali

UVA supports regional commercialization, investing directly in companies that take the University’s research and intellectual property to market and increasing the pace for new medical products that improve the health of Virginians and beyond.

Les Haughton, director of supplier diversity at UVA, works to help small, minority- or women-owned businesses become certified vendors.